Castle Biosciences Stock Market Value
| CSTL Stock | USD 33.67 0.25 0.75% |
| Symbol | Castle |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Castle Biosciences. Projected growth potential of Castle fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Castle Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.52) | Earnings Share (0.44) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets |
The market value of Castle Biosciences is measured differently than its book value, which is the value of Castle that is recorded on the company's balance sheet. Investors also form their own opinion of Castle Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Castle Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Castle Biosciences' market value can be influenced by many factors that don't directly affect Castle Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Castle Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Castle Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Castle Biosciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Castle Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Castle Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Castle Biosciences.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Castle Biosciences on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Castle Biosciences or generate 0.0% return on investment in Castle Biosciences over 90 days. Castle Biosciences is related to or competes with Myriad Genetics, CareDx, Personalis, Fulgent Genetics, Evolent Health, Geron, and DarioHealth Corp. Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing s... More
Castle Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Castle Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Castle Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 16.27 | |||
| Value At Risk | (2.88) | |||
| Potential Upside | 3.74 |
Castle Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Castle Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Castle Biosciences' standard deviation. In reality, there are many statistical measures that can use Castle Biosciences historical prices to predict the future Castle Biosciences' volatility.| Risk Adjusted Performance | 0.0016 | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.15) | |||
| Treynor Ratio | (0.04) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Castle Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Castle Biosciences February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0016 | |||
| Market Risk Adjusted Performance | (0.03) | |||
| Mean Deviation | 1.67 | |||
| Coefficient Of Variation | (14,775) | |||
| Standard Deviation | 2.58 | |||
| Variance | 6.63 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.15) | |||
| Treynor Ratio | (0.04) | |||
| Maximum Drawdown | 16.27 | |||
| Value At Risk | (2.88) | |||
| Potential Upside | 3.74 | |||
| Skewness | (1.28) | |||
| Kurtosis | 4.67 |
Castle Biosciences Backtested Returns
Castle Biosciences secures Sharpe Ratio (or Efficiency) of -0.0247, which signifies that the company had a -0.0247 % return per unit of risk over the last 3 months. Castle Biosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Castle Biosciences' Mean Deviation of 1.67, risk adjusted performance of 0.0016, and Standard Deviation of 2.58 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.64, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Castle Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Castle Biosciences is expected to be smaller as well. At this point, Castle Biosciences has a negative expected return of -0.0643%. Please make sure to confirm Castle Biosciences' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Castle Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.35 |
Poor reverse predictability
Castle Biosciences has poor reverse predictability. Overlapping area represents the amount of predictability between Castle Biosciences time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Castle Biosciences price movement. The serial correlation of -0.35 indicates that nearly 35.0% of current Castle Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.35 | |
| Spearman Rank Test | -0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 13.28 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Castle Biosciences Correlation, Castle Biosciences Volatility and Castle Biosciences Performance module to complement your research on Castle Biosciences. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Castle Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.